medigraphic.com
Instituto Nacional de Salud Pública

2014, Number 5

<< Back Next >>

salud publica mex 2014; 56 (5)

Cancer mortality trends in Mexico, 1980-2011

Torres-Sánchez LE, Rojas-Martínez R, Escamilla-Núñez C, de la Vara-Salazar E, Lazcano-Ponce E

Language: Spanish
References: 46
Page: 473-491
PDF size: 718.01 Kb.


ABSTRACT

Objective. To evaluate trends in cancer mortality in Mexico between 1980-2011. Material and methods. Through direct method and using World Population 2010 as standard population, mortality rates for all cancers and the 15 most frequent locations, adjusted for age and sex were calculated. Trends in mortality rates and annual percentage change for each type of cancer were estimated by joinpoint regression model. Results. As a result of the reduction in mortality from lung cancer (-3.2% -1.8% in men and in women), stomach (-2.1% -2.4% in men and in women) and cervix (-4.7%); since 2004 a significant (~1% per year) decline was observed in cancer mortality in general, in all ages, and in the group of 35-64 years of both sexes. Other cancers such as breast and ovarian cancer in women; as well as for prostate cancer in men, showed a steady increase. Conclusions. Some of the reductions in cancer mortality may be partially attributed to the effectiveness of prevention programs. However, adequate records of population-based cancer are needed to assess the real impact of these programs; as well as designing and evaluating innovative interventions to develop more costeffective prevention policies.


REFERENCES

  1. Stewart BW, Wild CP, ed. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer.

  2. International Agency for Research on Cancer. Globocan 2012: estimated cancer incidence, mortality and prevalence Worldwide in 2012 [sitio en internet]. WHO, 2012 [consultado el 31 de marzo de 2014]. Disponible en: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx

  3. Inegi. Mortalidad 2011 [documento en internet]. [consultado el 09 de junio de 2014]. Disponible en: http://www.inegi.org.mx/est/contenidos/ proyectos/registros/vitales/mortalidad/tabulados/ConsultaMortalidad.asp

  4. Malvezzi M, Bosetti C, Chatenoud L, Rodríguez T, Levi F, Negri E, et al. Trends in cancer mortality in Mexico, 1970-1999. Ann Oncol 2004;15:1712-1718.

  5. Bosetti C, Rodríguez T, Chatenoud L, Bertuccioa P, Levi F, Negri E, et al. Trends in cancer mortality in Mexico, 1981-2007. Eur J Cancer Prev 2011;20:355-363.

  6. Aldaco-Sarvide F, Pérez-Pérez P, Cervantes-Sánchez G, Torrecillas-Torres L, Erazo-VA. Mortalidad por cáncer en México, 2000-2010: el recuento de los daños. Gamo 2012;11:371-379.

  7. Tovar-Guzmán V, Hernández-Girón C, López-Ríos O, Lazcano-Ponce E. Prostate cancer mortality trends in Mexico, 1980-1995. Prostate 1999;39:23-27.

  8. Tovar-Guzmán V, López-Antunano FJ, Rodríguez-Salgado N. Trends in mortality from lung cancer in Mexico, 1980-2000. Rev Panam Salud Publica 2005;17:254-262.

  9. Lazcano-Ponce E, Palacio-Mejía LS, Allen-Leigh B, Yunes-Díaz E, Alonso P, Schiavon R. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birth rate, and the importance of diagnostic validity of cytology. Cancer Epidemiol Biomarkers Prev 2008;17:2808-2817.

  10. De la Vara-Salazar E, Suárez-López L, Ángeles-Llerenas A, Torres-Mejía G, Lazcano-Ponce E. Tendencias de la mortalidad por cáncer de mama en México, 1980-2009. Salud Publica Mex 2011;53:385-393.

  11. Méndez-Sánchez N, Villa AR, Vázquez-Elizondo G, Ponciano-Rodríguez G, Uribe M. Mortality trends for liver cancer in Mexico from 2000 to 2006. Ann Hepatol 2008;7:226-229.

  12. Tovar-Guzmán V, Hernández-Girón C, Barquera S, Rodríguez-Salgado N, López-Carrillo L. Epidemiologic panorama of stomach cancer mortality in Mexico. Arch Med Res 2001;32:312-317.

  13. Tovar-Guzmán V, Flores-Aldana M, Salmerón-Castro J, Lazcano-Ponce EC. Epidemiologic panorama of colorectal cancer in Mexico, 1980-1993. Dis Colon Rectum 1998;41:225-231.

  14. Anaya-Ruiz M, Vallejo-Ruiz V, Flores-Mendoza L, Pérez-Santos M. Female breast cancer incidence and mortality in Mexico, 2000-2010. Asian Pac J Cancer Prev 2014;15:1477-1479.

  15. Escamilla-Santiago RA, Narro-Robles J, Fajardo-Gutiérrez A, Rascón- Pacheco RA, López-Cervantes M. Tendencia de la mortalidad por cáncer en niños y adolescentes según grado de marginación en México, 1990- 2009. Salud Publica Mex 2012;54:587-594.

  16. Sinais. Base de datos de defunciones 1979-2011 [sitio en internet]. México: Secretaría de Salud [consultado el 02 de junio de 2013]. Disponible en: http://www.sinais.salud.gob.mx

  17. Consejo Nacional de Población. Proyecciones de la población de México, 1980-2030, 2005-2050. México: Conapo.

  18. Conapo. Proyecciones de la población de México, 1990-2010, 2010- 2050 [documento en internet]. México: Conapo [consultado el 16 de mayo de 2013]. Disponible en: http://www.conapo.gob.mx/es/CONAPO/ Proyecciones

  19. World Health Organization. International classification of disease: 9th revision. Geneva: WHO, 1977.

  20. World Health Organization. International classification of disease and related health problems: 10th revision. Geneva: WHO, 1992.

  21. United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: the 2012 revision, DVD edition [documento en internet]. ONU, 2013 [consultado el 17 de marzo de 2014]. Disponible en: http://www.un.org/en/development/desa/population/ index.shtml

  22. Bello B, Fadahun O, Kielkowski D, Nelson G. Trends in lung cancer mortality in South Africa: 1995-2006. BMC Public Health 2011;11:209-214.

  23. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-351.

  24. Chatenoud L, Bertuccio P, Bosetti C, Malvezzi M, Levi F, Negri E, La Vecchia C. Trends in mortality from major cancers in the americas: 1980- 2010. Ann Oncol 2014;Jun 6(pii):mdu206.

  25. Pereira-Scalabrino A, Almonte M, Dos-Santos-Silva I. Country-level correlates of cervical cancer mortality in Latin America and the Caribbean. Salud Publica Mex 2013;55:5-15.

  26. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados nacionales. 2a. ed. Cuernavaca, México: Instituto Nacional de Salud Pública, 2013.

  27. Torres J, López L, Lazcano E, Camorlinga M, Flores L, Muñoz O. Trends in Helicobacter pylori infection and gastric cancer in Mexico. Cancer Epidemiol Biomarkers Prev 2005;14:1874-1877.

  28. Christopoulou R, Lillard DR, Balmori de la Miyar JR. Smoking behavior of Mexicans: patterns by birth-cohort, gender, and education. Int J Public Health 2013;58:335-343.

  29. Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, Knaul F, Mohar A, Finkelstein DM, Goss PE. Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol 2012;13:e335-e343.

  30. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014;348:g366. doi: 10.1136/bmj.g366

  31. López Carrillo L, Suárez-López L, Torres-Sánchez L. Detección del cáncer de mama en México: síntesis de los resultados de la Encuesta Nacional de Salud Reproductiva. Salud Publica Mex 2009;51 supl 2:S345-S349.

  32. Sheley JF, Lessan GT. Limited impact of the breast self-examination movement: a Latin American illustration. Soc Sci Med 1986;23:905-910.

  33. Riman T, Nilsson S, Persson IR. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 2004;83:783-795.

  34. Lahmann PH, Cust AE, Friedenreich CM, Schulz M, Lukanova A, Kaaks R, et al. Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2010;126:2404-2415.

  35. Merritt MA, Cramer DW, Missmer SA, Vitonis AF, Titus LJ, Terry KL. Dietary fat intake and risk of epithelial ovarian cancer by tumour histology. Br J Cancer 2014;110:1392-1401.

  36. Inegi. Mujeres y hombres en México 2006. 10a ed. Aguascalientes: Inegi, 2006.

  37. Rivera JA, Barquera S, González-Cossío T, Olaiz G, Sepúlveda J. Nutrition transition in Mexico and in other Latin American countries. Nutr Rev 2004;62:S149-S157.

  38. Barquera S, Campos-Nonato I, Hernández-Barrera L, Flores M, Durazo-Arvizu R, Kanter R, Rivera JA. Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2009;51:S595-S603.

  39. Roman S, Zepeda-Carrillo EA, Moreno-Luna LE, Panduro A. Alcoholism and liver disease in Mexico: genetic and environmental factors. World J Gastroenterol 2013;19:7972-7982.

  40. Campollo O, Valencia-Salinas JJ, Berumen-Arellano A, Pérez-Aranda MA, Panduro-Cerda A, Segura-Ortega J. Características epidemiológicas de la cirrosis hepática en el Hospital Civil de Guadalajara. Salud Publica Mex 1997;39:195-200.

  41. Gómez-Guerra LS, Martínez-Fierro ML, Alcántara-Aragón V, Ortiz- López R, Martínez-Villarreal RT, Morales-Rodríguez IB, et al. Population-based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases. BMC Cancer 2009;9:91.

  42. Torres-Sánchez L, Vázquez-Salas RA, López-Carrillo L, Manzanilla-García HA, Cruz-Ortíz CH, Mendoza-Peña F, et al. Antecedentes de gonorrea y riesgo de cáncer de próstata en hombres mexicanos. Resultados preliminares. Rev Mex Urol 2013;73 supl 1:105-106.

  43. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002;37:806-813.

  44. Lozano R, Gómez-Dantés H, Garrido-Latorre F, Jiménez-Corona A, Campuzano-Rincón JC, Franco-Marina F, et al. La carga de enfermedad, lesiones, factores de riesgo y desafíos para el sistema de salud en México. Salud Publica Mex 2013;55:580-594.

  45. Léniz J, Barriga MI, Lagos M, Ibáñez C, Puschel K, Ferreccio C. HPV vaginal self-sampling among women non-adherent to Papanicolaou screening in Chile. Salud Publica Mex 2013;55:162-169.

  46. Guerrero-López CM, Muños-Hernández JA, Sáenz de Miera-Juárez B, Reynales-Shigematsu LM. Consumo de tabaco, mortalidad y política fiscal en México. Salud Publica Mex 2013;55 supl 2:S276-S281.




2020     |     www.medigraphic.com